在胰腺癌中NCAPG的诊断,预后和免疫作用:生物信息学分析

相关实验视频

Updated: Jul 28, 2026

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

Min Fang^1,2, Zhu Wu³, Zhi Xia⁴

¹Hunan Provincial Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, Changsha Medical University, Changsha, China.

|March 11, 2025

概括

非SMC凝聚素I复合体亚单元G (NCAPG) 是一个有前途的泛癌生物标志物. 它的高表达与诊断,预后和免疫透相关,表明有针对性的免疫疗法的潜力.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
生物信息学是一种生物信息学.

背景情况:

非SMC凝聚素I复合体亚单元G (NCAPG) 越来越多地与各种癌症的瘤进展有关.
在瘤发生过程中NCAPG的确切作用及其更广泛的影响仍然不完全理解.

研究的目的:

系统地研究NCAPG在各种癌症类型中的多方面的作用.
探索NCAPG的诊断和预后价值,以及它与瘤免疫微环境的关系.

主要方法:

利用生物信息学工具 (例如,STRING,GeneMANIA,开放目标) 来识别NCAPG相互作用分子和相关疾病.
分析了NCAPG表达和癌症功能状态,使用TCGA,GTEx和人类蛋白质图谱等数据库.
通过TIMER2.0和TISIDB评估NCAPG表达,免疫透和免疫分子之间的相关性.

主要成果:

在大多数癌症类型中,NCAPG表达显著上调.
在许多癌症中,NCAPG证明了诊断价值和预后意义.
NCAPG的表达与免疫细胞透和与免疫相关的分子相关,特别是在脏清细胞癌和甲状腺癌中.

结论:

NCAPG作为潜在的泛癌生物标志物用于诊断和预后.
NCAPG影响瘤免疫微环境,表明其在开发新型免疫疗法的潜在实用性.

更多相关视频

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

相关概念视频

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...